Ebola vaccine developed in Canada shows promising results

Via Top Health News -- ScienceDaily

A phase 1 randomized controlled trial has found an Ebola virus disease vaccine was well-tolerated with no safety concerns, and high antibodies were present in participants six months after immunization.

View original post here:

%d bloggers like this: